Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advanced BioScience Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011794
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract research and manufacturing company that provides services to life sciences industry. The company develops vaccines, therapeutics and other biologic products. It provides proof-of-concept in vivo studies with preclinical immunomonitoring, potency testing and efficacy. ABL’s services include technology transfer, upstream cell culture, and others. The company offers contract research services and contract manufacturing services, which include virus seed stock development, plaque purification, cGMP virus banking, viral lysate production, upstream process development, downstream purification development, production of toxicology supply and production of clinical supply. ABL is headquartered in Rockville, Maryland, the US.

Advanced BioScience Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Advanced BioScience Labs Acquires Production Asset of Transgene 10
Partnerships 11
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Asset Transactions 13
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc – Key Competitors 15
Advanced BioScience Laboratories Inc – Key Employees 16
Advanced BioScience Laboratories Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
May 11, 2017: ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line 18
Government and Public Interest 19
Jul 26, 2016: The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support 19
Mar 03, 2016: ABL Part of Team Awarded $900 Million IDIQ Contract by U.S. Army for Medical Product Research and Development 20
Other Significant Developments 21
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advanced BioScience Labs Acquires Production Asset of Transgene 10
ABL Enters into Contract Manufacturing Agreement with RegenxBio 11
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 12
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 13
Advanced BioScience Laboratories Inc, Key Competitors 15
Advanced BioScience Laboratories Inc, Key Employees 16
Advanced BioScience Laboratories Inc, Subsidiaries 17

★海外企業調査レポート[Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Muang Thai Insurance PCL:企業の戦略・SWOT・財務分析
    SummaryMuang Thai Insurance PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Beadell Resources Ltd:企業のM&A・事業提携・投資動向
    Beadell Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beadell Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • KAHR medical Ltd.(製薬・医療分野):企業M&A動向
    Summary KAHR medical Ltd. (KAHR) is a pharmaceutical company. The company develops fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its products include KAHR-101, KAHR-102, and KAHR-103. Its KAHR-101 is a fusion-protein used for the treatment in animal disease mode …
  • Precision System Science Co., Ltd. (7707):企業概要、財務及び戦略的SWOT分析
    Summary Precision System Science Co., Ltd. (PSS) is a medical device company. The company develops, manufactures and sells automated systems, instruments, software and others. Its products include automated nucleic acid isolation system, microarray sample preparation system, magnetic beads based mul …
  • Arsenal Medical Inc:企業のM&A・提携動向(医療機器分野)
    Summary Arsenal Medical Inc (Arsenal) is a medical technology company that develops polymer based foams and fibers. The company’s products include foam system for acute hemorrhage and DARPA collaboration products. Its foam system is an in-situ foaming foams, which is designed for the control of seve …
  • CK Life Sciences Int’l., (Holdings) Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CK Life Sciences Int'l., (Holdi …
  • Unitil Corporation (UTL):企業財務及び戦略的SWOT分析
    Summary Unitil Corporation (Unitil) is an energy utility company that offers construction, operation, and maintenance gas and electric distribution systems. The company distributes and supplies electricity and natural gas to its customers. Its business operations comprise electricity distribution, g …
  • Canon Inc. (7751):企業のM&A・提携動向(医療機器分野)
    Summary Canon, Inc. (Canon) is one of the leading manufacturers of office multifunction devices (MFDs), inkjet printers, laser printers, plain paper copying machines, cameras and lithography equipment. Its major products include office copying machines, personal-use copying machines, laser MFDs rela …
  • Objective Corporation Limited (OCL):企業の財務及び戦略的SWOT分析
    Summary Objective Corporation Limited (Objective) is technical service provider that offers process management solutions. The company’s products include drawing management, enterprise search, architecture, adoption and mobility, web content management, records management, document management and oth …
  • SuppreMol GmbH:企業のM&A・提携動向(医療分野)
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • JBCC Holdings Inc. (9889):企業財務及び戦略的SWOT分析
    Summary JBCC Holdings Inc. (JBCC) is a technology consulting company that provides software solutions. The company offers information solutions, distribution, product development and manufacturing; and shared services. Its information solutions include consulting, application development, system dev …
  • Mingyuan Medicare Development Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mingyuan Medicare Development C …
  • Keane Group Inc (FRAC):企業の財務・戦略的SWOT分析
    Keane Group Inc (FRAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bedoukian Research, Inc.:企業の戦略・SWOT・財務分析
    SummaryBedoukian Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Piquadro SpAの企業概要及び財務/SWOT分析
    Piquadro SpA Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecast …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lime Energy Co. (LIME):企業財務及び戦略的SWOT分析
    Summary Lime Energy Co. (Lime Energy) is an energy company that offers technical services. The company’s activities include energy engineering and auditing, logistics and construction management, warehousing, and local contracting implementation capabilities. Its energy services include customer eng …
  • Expresso Fitness:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Expresso Fitness Mergers and Ac …
  • NJK Corporation (9748):企業概要、財務及び戦略的SWOT分析
    Summary NJK Corporation (NJK) is an information technology service provider. The company’s business activities include software development, network and system devices sales, and software package development and sales. Its products include DataNature series, OCR-related products, condominium managem …
  • Freedom Communications, Inc.:企業のM&A・提携・投資分析
    Freedom Communications, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Freedom Communications, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆